MEHCQ (Chrome Holding Co) ROC (Joel Greenblatt) %: -7,617.74% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEHCQ Chrome Holding Co MEHCQ
58 GF Score
Price $3.50
View Full Analysis

What is Chrome Holding Co ROC (Joel Greenblatt) %?

Chrome Holding Co MEHCQ -2.78% 58 ROC (Joel Greenblatt) % is -7,617.74% as of Jun. 2025. GuruFocus rates MEHCQ with a GF Score™ of 58/100.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Chrome Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was -7,617.74%.

The historical rank and industry rank for Chrome Holding Co's ROC (Joel Greenblatt) % or its related term are showing as below:

MEHCQ's ROC (Joel Greenblatt) % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -2.61
* Ranked among companies with meaningful ROC (Joel Greenblatt) % only.

Chrome Holding Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Chrome Holding Co  (OTCPK:MEHCQ) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Chrome Holding Co ROC (Joel Greenblatt) % Related Terms


Chrome Holding Co ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Chrome Holding Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chrome Holding Co ROC (Joel Greenblatt) % Chart

Chrome Holding Co Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial -149.34 -221.55 -222.94 -290.15 -574.19

Chrome Holding Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -328.38 -162.57 -685.38 -7,617.74 0.00

MEHCQ vs BDSX, XGN, FONR: ROC (Joel Greenblatt) % Comparison

For the Diagnostics & Research subindustry, Chrome Holding Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chrome Holding Co ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Chrome Holding Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Chrome Holding Co's ROC (Joel Greenblatt) % falls into.


MEHCQ
58GF Score
Chrome Holding Co MEHCQ
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chrome Holding Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.352 + 15.558 + 27.673) - (57.412 + 49.347 + 9.635)
=-71.811

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.226 + 13.417 + 16.5) - (94.468 + 41.057 + 6.234)
=-110.616

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Chrome Holding Co for the quarter that ended in Jun. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Jun. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-122.836/( ( (1.791 + max(-71.811, 0)) + (1.434 + max(-110.616, 0)) )/ 2 )
=-122.836/( ( 1.791 + 1.434 )/ 2 )
=-122.836/1.6125
=-7,617.74 %

Note: The EBIT data used here is four times the quarterly (Jun. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -7,617.74% mean?
Chrome Holding Co (MEHCQ) has a ROC (Joel Greenblatt) % of -7,617.74% as of Jun. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Chrome Holding Co and its competitors.
Is Chrome Holding Co's ROC (Joel Greenblatt) % too high?
Chrome Holding Co's current ROC (Joel Greenblatt) % is -7,617.74%. Overall, Chrome Holding Co has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Chrome Holding Co's ROC (Joel Greenblatt) % compare to BDSX and XGN?
Chrome Holding Co's ROC (Joel Greenblatt) % of -7,617.74% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Chrome Holding Co and its competitors. Chrome Holding Co's current ROC (Joel Greenblatt) % is -7,617.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrome Holding Co stock overvalued right now?
Chrome Holding Co (MEHCQ) has a current ROC (Joel Greenblatt) % of -7,617.74%. The current ROC (Joel Greenblatt) % is -7,617.74%. Chrome Holding Co's overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Chrome Holding Co (MEHCQ), the current ROC (Joel Greenblatt) % is -7,617.74% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chrome Holding Co Business Description

Address 870 Market Street, Room 415, South San Francisco, CA, USA, 94102
Chrome Holding Co, formerly known as 23andMe Holding Co, is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes one main sector that is Consumer and Research Services. The company generates maximum revenue from the Consumer and Research Services segment.
58GF Score

Get the complete analysis for MEHCQ

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price